Cardiovascular Devices are used in treating diseases related to the heart and the circulatory system. A Peripheral Vascular Stent is an expandable perforated tube that is inserted into a peripheral vessel to prevent blood flow constriction. GlobalData uses proprietary data and analytics to provide a comprehensive report on the peripheral vascular stents devices market, including market shares of different players within Australia. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the peripheral vascular stents market in Australia was W. L. Gore & Associates followed by Boston Scientific, CR Bard, Cook Medical, Abbott Laboratories, Cordis, Medtronic, Biotronik SE, Terumo and Getinge.
Peripheral Bare Metal Stents, Peripheral Drug Eluting Stents, Peripheral Covered Stents and Peripheral Bioabsorbable Stents are covered under Peripheral Vascular Stents. A stent refers to a stent delivery system. Peripheral Bare Metal Stents are a mesh-like tubes structured thin wire without coating. A Peripheral Drug Eluting Stent is a mesh-like tube structured thin wire present with a coating of drug or medicine to help prevent the arteries from re-stenosis. Peripheral Covered Stents are flexible tubes used to repair or support a damaged section of an artery. A Peripheral Bioabsorbable Stent is manufactured from a bio-absorbable material that might get dissolved or absorbed in the body.
The value of the peripheral vascular stents devices market within Australia was expected to be over $20m in 2023.
For the latest complete market share analysis of peripheral vascular stents device market in Australia, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
